B Cell-Based Vaccine Transduced With ESAT6-Expressing Vaccinia Virus and Presenting α-Galactosylceramide Is a Novel Vaccine Candidate Against ESAT6-Expressing Mycobacterial Diseases

Early secretory antigenic target-6 (ESAT6) is a potent immunogenic antigen expressed in Mycobacterium tuberculosis as well as in some non-tuberculous mycobacteria (NTM), such as M. kansasii. M. kansasii is one of the most clinically relevant species of NTM that causes mycobacterial lung disease, whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Bo-Eun, Ahn, Jae-Hee, Park, Eun-Kyoung, Jeong, Hyunjin, Lee, Hyo-Ji, Jung, Yu-Jin, Shin, Sung Jae, Jeong, Hye-Sook, Yoo, Jung Sik, Shin, EunKyoung, Yeo, Sang-Gu, Chang, Sun-Young, Ko, Hyun-Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830241/
https://www.ncbi.nlm.nih.gov/pubmed/31736965
http://dx.doi.org/10.3389/fimmu.2019.02542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830241/
https://www.ncbi.nlm.nih.gov/pubmed/31736965
http://dx.doi.org/10.3389/fimmu.2019.02542

Ejemplares similares